Better Health for All

MEDICLIN AG's core business, operating hospitals and rehabilitation clinics, inherently provides substantial health benefits. The company's inpatient cases increased to 107,956 in 2023 and 104,816 in 2022, with occupancy rates rising to 83.9% in 2023 and 78.0% in 2022.

Sales across its post-acute, acute, and nursing care segments consistently grew, reaching a record EUR 748.8 million in 2024. There is no evidence of revenue from products or activities with negative health outcomes. While the company anticipates rising demand for preventative care, its primary focus remains on treatment, with no specific data on investment in preventative measures. The company mentions treating Post- and Long-COVID patients, indicating some mental health support, but lacks comprehensive programs or resource allocation data, suggesting limited practical support.

Fair Pay & Worker Respect

The company's employee satisfaction, as indicated by Glassdoor reviews, shows an overall satisfaction score of 3.65 out of 5, which translates to an engagement score of 73 out of 100.

MEDICLIN is committed to the UN Declaration of Human Rights and the Charter of Fundamental Rights of the European Union, prohibiting discrimination based on various characteristics and promoting equal opportunities in salary and career. The company ensures workplace safety through regular inspections, risk identification, and training courses. In 2017, five compliance audits were conducted with no reported compliance violations. As of December 31, 2022, the proportion of women at management level below the Management Board was 42.9%, exceeding the target of at least 20% by June 30, 2027. The Supervisory Board had an equal number of women and men (eight each) as of December 31, 2022.

Honest & Fair Business

MEDICLIN AG has a formal whistleblower protection policy in place, with confidential reporting to the chief compliance officer, but there is no evidence of independent investigation processes.

The company has a Code of Conduct and MEDICLIN Attitude Principles that prohibit corruption, bribery, gifts, and financial donations. Compliance training is provided to new and promoted commercial directors, but the frequency and effectiveness metrics are not detailed. The company's ethical claims and compliance are independently verified through certifications (e.g., ISO 9001:2015) and audits, including a voluntary limited assurance audit of its non-financial declaration by PricewaterhouseCoopers according to ISAE 3000. Consolidated financial statements and group interim reports are audited by PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft, but the percentage of revenue, assets, or subsidiaries covered is not specified. The Supervisory Board considers some members independent despite long tenure, but a specific percentage of conflict-free board members is not provided.

Planet-Friendly Business

The company's total Scope 1, 2, and 3 greenhouse gas emissions were 27,095 tCO₂e in 2022, a decrease of 7.97% from 29,440 tCO₂e in 2021.

The share of operational energy consumption sourced from renewables was 57.2% in 2021, a decrease from 65.0% in 2020. For capital expenditure, 29.0% was taxonomy-eligible, but 0.0% was taxonomy-aligned with the EU Sustainable Taxonomy. Climate scenario analysis is performed, considering 1.5°C, 2°C, and 3°C+ pathways, with physical risks assessed as immaterial.

Respect for Cultures & Communities

The company has no reported cultural appropriation incidents, and its business model as a healthcare provider in Germany means that FPIC processes, indigenous suppliers, and cultural site protection are not applicable.

MEDICLIN supports local activities promoting health in clubs or schools, which is general charitable giving without a specific cultural heritage focus. The company's website offers content in both German and English, but its IR-Newsletter is available in German only, indicating limited local language incorporation beyond the primary operating language. There is no specific cultural incident response framework mentioned.

Safe & Smart Tech

The provided articles do not contain specific, concrete data points for MEDICLIN AG regarding any of the 'Safe & Smart Tech' KPIs. Information such as data breach severity, cybersecurity investment, privacy certifications, security training effectiveness, encryption implementation, AI ethics governance, AI audit practices, algorithmic transparency, unauthorized data use, user data control, authentication security, vulnerability management, bug bounty effectiveness, privacy by design, security testing coverage, data minimization, regulatory compliance, algorithmic harm remediation, or digital rights advocacy is explicitly stated as 'no specific information found' or is not present.

Therefore, no KPIs can be scored based on the available evidence.

Zero Waste & Sustainable Products

The provided articles, including MEDICLIN AG's 2023 annual report, explicitly state a lack of quantitative data for all relevant KPIs under the 'Zero Waste & Sustainable Products' value.

Specifically, no data is available for waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability scores, waste audit frequency, zero waste certifications, or waste disposal violations. The reports also do not provide information on material efficiency, packaging to product ratio, waste reduction targets, supplier waste requirements, or customer waste education programs.